Trial to Compare eConsent With Standard Consent Among Prospective Biobank Participants
Completed · Not applicable
Conditions studied: Lynch Syndrome
In brief
The goal of this trial is to determine whether the Sage eConsent framework (presented using an electronic application) is non-inferior to traditional, paper-based, human-mediated consent-and therefore could be part of an acceptable population screening approach to identifying patients and others with actionable hereditary syndromes-and to increase basic knowledge about patients' informational needs about different aspects of genetic/omic screening. After receiving either 1) the traditional consenting approach, or 2) a consenting approach presented on an electronic tablet, the investigators will test for differences between these two arms in a variety of outcome measures including objective and perceived comprehension, time spent and informational needs, and enrollment decision, among others.
Key facts
- Study ID
- NCT04131062
- Run by
- Geisinger Clinic
- People needed
- 703
- Starts
- 2019-11-01
- Expected to finish
- 2022-05-19
- Last updated by the study team
- 2022-12-27
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- None
You may not qualify if…
- None
Where it is running
- Geisinger — Danville, Pennsylvania, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.